During shipping/storage, three temperature excursions are allowed in total, across any of the listed temperature conditions.1
The stability of single-dose zolbetuximab vials was evaluated under thermal cycling, stress, and accelerated conditions.1 No impact on quality was observed from all three tests for both 100 mg and 300 mg vials.
Table 1. Allowable temperature excursion range during shipping/storage for zolbetuximab 1
Strength | Formulation | Package configuration | Allowable temperature excursion | Allowable temperature excursion |
|---|---|---|---|---|
High sidea | Low sidea | |||
100 mg | Global (single) | Vial | 40°C for 3 days 30°C for 6 days 25°C for 14 days | -20°C for 7 days |
300 mg | Global (single) | Vial | 40°C for 3 days 30°C for 6 days 25°C for 14 days | -20°C for 7 days |
a Three temperature excursions are allowed in total.
If you are not able to find the information through the Search function, please contact our Medical Communications and Engagement Department by using any of the channels below:
The medical information on this website is for educational purposes only and is intended to provide scientific information about Astellas products. This information is not intended as medical advice or clinical recommendations. This website is for use only by United States residents and licensed healthcare professionals (HCPs) practicing in the United States. Product labeling may vary between countries.
Please choose an option that best describes you:
For visitors outside the United States: click here